[HTML][HTML] Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker …
CM de Ravenstein, C Bouzin, S Lazam, J Boulif… - Journal of …, 2015 - Elsevier
Abstract Background Gadolinium (Gd) Extracellular volume fraction (ECV) by
Cardiovascular Magnetic Resonance (CMR) has been proposed as a non-invasive method …
Cardiovascular Magnetic Resonance (CMR) has been proposed as a non-invasive method …
Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy
S Nakamori, K Dohi, M Ishida, Y Goto… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The purpose of this study was to examine the histological correlation of native
myocardial T1 and extracellular volume fraction (ECV) measurement at 3-T for the …
myocardial T1 and extracellular volume fraction (ECV) measurement at 3-T for the …
T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy
F aus dem Siepen, SJ Buss… - European Heart …, 2015 - academic.oup.com
Aim The aim of this study was to determine the value of extracellular volume fraction (ECV)
for the non-invasive assessment of diffuse myocardial fibrosis (MF) in different stages of …
for the non-invasive assessment of diffuse myocardial fibrosis (MF) in different stages of …
[HTML][HTML] Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus …
EB Schelbert, SM Testa, CG Meier, WJ Ceyrolles… - Journal of …, 2011 - Elsevier
Background Myocardial extravascular extracellular volume fraction (Ve) measures quantify
diffuse fibrosis not readily detectable by conventional late gadolinium (Gd) enhancement …
diffuse fibrosis not readily detectable by conventional late gadolinium (Gd) enhancement …
[HTML][HTML] Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials
Background Cardiac magnetic resonance (CMR) T1 mapping has been used to characterize
myocardial diffuse fibrosis. The aim of this study is to determine the reproducibility and …
myocardial diffuse fibrosis. The aim of this study is to determine the reproducibility and …
[HTML][HTML] Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience
Background Diffuse myocardial fibrosis, and to a lesser extent global myocardial edema, are
important processes in heart disease which are difficult to assess or quantify with …
important processes in heart disease which are difficult to assess or quantify with …
Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans
Background—Diffuse myocardial fibrosis is a final end point in most cardiac diseases. It is
missed by the cardiovascular magnetic resonance (CMR) late gadolinium enhancement …
missed by the cardiovascular magnetic resonance (CMR) late gadolinium enhancement …
Native T1 relaxation time and extracellular volume fraction as accurate markers of diffuse myocardial fibrosis in heart valve Disease–comparison with targeted left …
R Kockova, P Kacer, J Pirk, J Maly, L Sukupova… - Circulation …, 2016 - jstage.jst.go.jp
Background: The aim of our study was to investigate the relationship between the cardiac
magnetic resonance (CMR)-derived native T1 relaxation time and myocardial extracellular …
magnetic resonance (CMR)-derived native T1 relaxation time and myocardial extracellular …
Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis
LM Iles, AH Ellims, H Llewellyn, JL Hare… - European Heart …, 2015 - academic.oup.com
Aim Myocardial fibrosis is fundamental in the pathogenesis of heart failure. Late gadolinium
enhancement (LGE) with cardiac magnetic resonance (CMR) imaging is commonly …
enhancement (LGE) with cardiac magnetic resonance (CMR) imaging is commonly …
CMR–derived extracellular volume fraction as a marker for myocardial fibrosis: the importance of coexisting myocardial inflammation
JA Lurz, C Luecke, D Lang, C Besler… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The aim of the present study was to evaluate whether extracellular volume
fraction (ECV) can reliably inform on the extent of diffuse fibrosis in the simultaneous …
fraction (ECV) can reliably inform on the extent of diffuse fibrosis in the simultaneous …
相关搜索
- extracellular volume fraction myocardial fibrosis
- dilated cardiomyopathy myocardial fibrosis
- histological validation look locker
- volume fraction histological validation
- preliminary validation myocardial fibrosis
- volume fraction look locker
- aortic stenosis myocardial fibrosis
- endomyocardial biopsy myocardial fibrosis
- asymptomatic patients myocardial fibrosis
- relaxation time myocardial fibrosis
- accurate markers myocardial fibrosis
- volume fraction interstitial myocardial fibrosis
- extracellular volume mapping myocardial fibrosis
- extracellular volume fraction myocardial inflammation